Related Experiment Video
Updated: Jun 16, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
MST1/Drp1 axis mediates microglia pro-inflammatory activation following cerebral ischemia-reperfusion injury
Yao Mu1,2, Jianping Liu3, Yi Dong4
1The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264000, Shandong, China.
Abstract:
The present study investigated the role of the mammalian sterile 20-like kinase 1/dynamin-related protein 1 (MST1/Drp1) axis in regulating microglia pro-inflammatory activation during cerebral ischemia-reperfusion injury (CIRI). An in vivo model of middle cerebral artery occlusion/reperfusion (MCAO/R) in rats and an in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) model in BV-2 microglial cells and primary microglia were established. Inhibitors of MST1 (XMU-MP-1) or/and Drp1 (Mdivi-1), along with genetic approaches including siMST1-mediated knockdown and plasmid-based overexpression, were utilized in the models. The expression and activation of MST1 and Drp1, mitochondrial morphology changes, microglia pro-inflammatory activation makers, pro-inflammatory cytokine release, DNA fragmentation and neurological function were evaluated. The findings indicated that reperfusion or reoxygenation led to a rise in total and phosphorylation levels of MST1 and Drp1. The reperfusion also facilitated the Drp1 translocation toward mitochondria, and resulted in increased mitochondrial morphological changes. MST1 or/and Drp1 inhibitors decreased p-MST1 and p-Drp1(Ser616) levels, attenuated mitochondrial fission, suppressed microglia pro-inflammatory activation, pro-inflammatory factors release (TNF-α, IL-6 and IL-1β). Overall, these effects ultimately mitigated cerebral injury as evidenced by reduced DNA fragmentation, decreased cerebral infarct volumes, and improved neurological function. Combined inhibitors further exerted ameliorative effects on the above-mentioned parameters. In the in vitro experiments, siMST1 knockdown attenuated p-Drp1(Ser616) expression and suppressed microglia pro-inflammatory activation under OGD/R conditions. These protective effects were reversed by Drp1 overexpression. These findings indicate that p-MST1 drives microglia pro-inflammatory activation via promoting the p-Drp1(Ser616)-mediated excessive mitochondrial fission during CIRI.
Insights
The mammalian sterile 20-like kinase 1/dynamin-related protein 1 (MST1/Drp1) axis drives microglia inflammation after stroke. Inhibiting MST1 or Drp1 reduces brain injury by decreasing mitochondrial fission and pro-inflammatory responses.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Cerebral ischemia-reperfusion injury (CIRI) triggers neuroinflammation, involving microglia activation.
- The mammalian sterile 20-like kinase 1/dynamin-related protein 1 (MST1/Drp1) pathway is implicated in cellular stress responses.
Purpose of the Study:
- To investigate the role of the MST1/Drp1 axis in microglia pro-inflammatory activation during CIRI.
- To determine if targeting MST1/Drp1 can mitigate brain injury.
Main Methods:
- Established in vivo (MCAO/R in rats) and in vitro (OGD/R in BV-2 cells and primary microglia) models of CIRI.
- Utilized MST1/Drp1 inhibitors (XMU-MP-1/Mdivi-1) and genetic manipulation (siMST1, Drp1 overexpression).
- Assessed MST1/Drp1 expression/activation, mitochondrial morphology, microglia activation markers, cytokine release, DNA fragmentation, and neurological function.
Main Results:
- Reperfusion/reoxygenation increased MST1 and Drp1 phosphorylation and Drp1 mitochondrial translocation, leading to excessive mitochondrial fission.
- MST1 or Drp1 inhibition reduced p-MST1/p-Drp1(Ser616), attenuated mitochondrial fission, and suppressed microglia pro-inflammatory activation and cytokine release (TNF-α, IL-6, IL-1β).
- Genetic knockdown of MST1 reduced p-Drp1(Ser616) and microglia activation, effects reversed by Drp1 overexpression.
Conclusions:
- The p-MST1/p-Drp1(Ser616) axis promotes microglia pro-inflammatory activation via excessive mitochondrial fission during CIRI.
- Inhibiting the MST1/Drp1 pathway offers a potential therapeutic strategy for mitigating cerebral injury.
- Combined inhibition of MST1 and Drp1 demonstrated enhanced protective effects.

